- New treatment options of transitional cell carcinoma of the urinary bladder in the era of immunotherapy2021 | Third Faculty of Medicine
- Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract2009 | Second Faculty of Medicine
- Urine and Serum Cathepsin B Concentrations in the Transitional Cell Carcinoma of the Bladder2012 | Second Faculty of Medicine
- Carbonic anhydrase IX (CA IX)expression in renal cell carcinoma and transitional cell carcinoma of urinary tract2011 | Second Faculty of Medicine
- Management of transitional cell carcinoma of the upper urinary tract2000 | First Faculty of Medicine
- DNA ploidity in transitional cell carcinoma of the urinary bladderPublication without faculty affiliation
- Survivin in nonivasive diagnosis of transitional cell carcinoma of the urinary bladderPublication without faculty affiliation
- Immunotherapy of Superficial Bladder Transitional Cell Carcinoma by BCG Side Effects1999 | Second Faculty of Medicine, Central Library of Charles University
- Urine survivin in nonivasive diagnosis of transitional cell carcinoma of the urinary bladder2010 | First Faculty of Medicine
- Urine survivin in non-invasive diagnosis of transitional cell carcinoma of the urinary bladderPublication without faculty affiliation
- Association of Pax5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder2006 | Second Faculty of Medicine
- Study of cellular DNA content by flow cytometry in transitional cell carcinoma of the urinary bladderPublication without faculty affiliation
- Evaluation of PAX5 gene expression in patients with transitional cell carcinoma of the urinary bladder and its prognostic valuePublication without faculty affiliation
- Urine tumour associated trypsin inhibitor (TATI) in diagnosis and prognosis of transitional cell carcinoma of the bladder2015 | First Faculty of Medicine, Second Faculty of Medicine
- Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells2007 | Third Faculty of Medicine
- Concomitant Seminal Vesicle Invasion in pT4a Urothelial Carcinoma of the Bladder with Contiguous Prostatic Infiltration is an Adverse Prognosticator for Cancer-Specific Survival after Radical Cystectomy2014 | Second Faculty of Medicine
- Iodine Content Analysis Using Dual-Energy Computed Tomography as a Biomarker of Transitional Cell Carcinoma, an Experience with Separation of the Clotted Blood and Tumorous Tissue2018 | Faculty of Medicine in Pilsen
- What Are the Limitations of Endoscopic Management of Urothelial Carcinoma of the Upper Urinary Tract?2011 | Second Faculty of Medicine
- Association of developmental control gene PAX5 expression and clinical outcome in patients with superficial transitional cell carcinoma (TCC) of the bladderPublication without faculty affiliation
- Can urinary BTA TRAK and UBC IRMA predict the risk of recurrence in patients with Ta T1 bladder transitional cell carcinoma (TCC)?Publication without faculty affiliation
- Differences in gene expression between transitional cell carcinoma of the human bladder with short and prolonged recurrence-free period using oligonucleotide microarraysPublication without faculty affiliation
- 5-aminolevulinic acid induced fluorescence cystoscopy and its influence on early and late recurrence rate in superficial bladder transitional cell carcinoma (TCC)Publication without faculty affiliation
- The role of sequential evaluation of BTA TRAK and UBC IRMA in urine during follow-up in patients with Ta T1 bladder transitional cell carcinoma (TCC)Publication without faculty affiliation
- Expression of the developmental control gene PAX5 in bladder transitional cell carcinoma, its prognostic value and correlation with p53 immunohistochemistry and p53 mutation analysis +1Publication without faculty affiliation
- Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: Overview and the Unmet Clinical Need for Alternative Adjuvant Therapy as Studied in the MAGNOLIA Trial2014 | Second Faculty of Medicine
- Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer2006 | Second Faculty of Medicine
- Expression of BCL-2 and BAX-1 genes in the tissue of Ta, T1 urothelial carcinoma and their prognostic value2013 | First Faculty of Medicine, Second Faculty of Medicine
- Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery2012 | Second Faculty of Medicine
- Diagnostic Efficiency of Serum and Urine Procathepsin B and Cathepsin B in Patients with Carcinoma of the Urinary Bladder2016 | Second Faculty of Medicine